102 related articles for article (PubMed ID: 1861941)
21. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
22. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
[TBL] [Abstract][Full Text] [Related]
24. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
Pizzo PA; Butler K; Balis F; Brouwers E; Hawkins M; Eddy J; Einloth M; Falloon J; Husson R; Jarosinski P
J Pediatr; 1990 Nov; 117(5):799-808. PubMed ID: 2172501
[TBL] [Abstract][Full Text] [Related]
25. Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.
Güngör T; Funk M; Linde R; Kynast I; Allendorf A; Lotz C; Ehrenforth S; Hofmann D; Kornhuber B; Kreuz W
Eur J Pediatr; 1993 Aug; 152(8):650-4. PubMed ID: 8104791
[TBL] [Abstract][Full Text] [Related]
26. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
Boucher FD; Modlin JF; Weller S; Ruff A; Mirochnick M; Pelton S; Wilfert C; McKinney R; Crain MJ; Elkins MM
J Pediatr; 1993 Jan; 122(1):137-44. PubMed ID: 8419601
[TBL] [Abstract][Full Text] [Related]
27. The pharmacokinetics of zidovudine administered by continuous infusion in children.
Balis FM; Pizzo PA; Murphy RF; Eddy J; Jarosinski PF; Falloon J; Broder S; Poplack DG
Ann Intern Med; 1989 Feb; 110(4):279-85. PubMed ID: 2643914
[TBL] [Abstract][Full Text] [Related]
28. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.
Pizzo PA; Eddy J; Falloon J; Balis FM; Murphy RF; Moss H; Wolters P; Brouwers P; Jarosinski P; Rubin M
N Engl J Med; 1988 Oct; 319(14):889-96. PubMed ID: 3166511
[TBL] [Abstract][Full Text] [Related]
29. Better AIDS treatments.
Minn Med; 1991 Aug; 74(8):42. PubMed ID: 1656183
[No Abstract] [Full Text] [Related]
30. Zidovudine: experience at the Newcastle Haemophilia Centre.
Jones P
J Infect; 1989 Jan; 18 Suppl 1():53-8. PubMed ID: 2783716
[TBL] [Abstract][Full Text] [Related]
31. Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.
Brady MT; McGrath N; Brouwers P; Gelber R; Fowler MG; Yogev R; Hutton N; Bryson YJ; Mitchell CD; Fikrig S; Borkowsky W; Jimenez E; McSherry G; Rubinstein A; Wilfert CM; McIntosh K; Elkins MM; Weintrub PS
J Infect Dis; 1996 May; 173(5):1097-106. PubMed ID: 8627060
[TBL] [Abstract][Full Text] [Related]
32. [The effect of high-dose peroral zidovudine treatment in a 4-year-old child with HIV encephalopathy].
Zenz W; Lackner H; Maurer U; Ranner G; Puchhammer-Stöckl E
Padiatr Padol; 1992; 27(1):11-5. PubMed ID: 1560990
[TBL] [Abstract][Full Text] [Related]
33. Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity.
Warrier I; Lusher JM
Am J Pediatr Hematol Oncol; 1990; 12(2):160-3. PubMed ID: 2378412
[TBL] [Abstract][Full Text] [Related]
34. Zidovudine (AZT) therapy in children with HIV infection: the Australian experience.
Palasanthiran P; Ziegler JB; Kemp AS; Ekert H; Jupe DM; Gatenby PA; Keller AJ; Smales O
J Paediatr Child Health; 1990 Oct; 26(5):257-62. PubMed ID: 1702296
[TBL] [Abstract][Full Text] [Related]
35. Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.
Lee BL; Safrin S; Makrides V; Gambertoglio JG
Antimicrob Agents Chemother; 1996 May; 40(5):1231-6. PubMed ID: 8723472
[TBL] [Abstract][Full Text] [Related]
36. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
Creagh-Kirk T; Doi P; Andrews E; Nusinoff-Lehrman S; Tilson H; Hoth D; Barry DW
JAMA; 1988 Nov; 260(20):3009-15. PubMed ID: 3263514
[TBL] [Abstract][Full Text] [Related]
37. A reduced dose of zidovudine in patients with AIDS.
N Engl J Med; 1991 Apr; 324(14):994-6. PubMed ID: 2053945
[No Abstract] [Full Text] [Related]
38. A national survey on the care of infants and children with human immunodeficiency virus infection.
Kline MW; Shearer WT
J Pediatr; 1991 May; 118(5):817-21. PubMed ID: 2019940
[No Abstract] [Full Text] [Related]
39. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
van Leeuwen R; van den Hurk PJ; Jöbsis GJ; van der Wouw PA; Reiss P; Eeftinck Schattenkerk JK; Danner SA; Lange JM
Genitourin Med; 1990 Dec; 66(6):418-22. PubMed ID: 2125023
[TBL] [Abstract][Full Text] [Related]
40. Criteria for use of zidovudine in adult and pediatric inpatients and outpatients.
Goodwin SD; Shipp KW
Clin Pharm; 1992 Jan; 11(1):63-8. PubMed ID: 1730181
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
